RELMADA THERAPEUTICS, INC. Earnings Per Share (Basic)
RELMADA THERAPEUTICS, INC. (RLMD) reported Earnings Per Share (Basic) of -$0.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.11.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.22.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.61, a 69.78% decline year-over-year.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.30.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$1.45.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$2.65.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$3.28.
- RELMADA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$5.30.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.11 10-Q · filed 2026-08-06 | -$0.32 10-Q · filed 2026-08-06 | $0.06 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-12 | $0.25 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-12-31 | $0.61 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.58 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.41 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.45 10-K · filed 2026-03-19 | |||
| 2025-09-30 | -$0.30 10-Q · filed 2025-11-13 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.16 10-Q · filed 2025-11-13 | $0.75 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-06-30 | -$0.30 10-Q · filed 2026-08-06 | -$0.86 10-Q · filed 2026-08-06 | $1.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.39 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-03-31 | -$0.58 10-Q · filed 2026-05-12 | $1.44 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.73 derived: net income ÷ weighted average shares · filed 2026-08-06 | $0.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2024-12-31 | $2.03 derived: net income ÷ weighted average shares · filed 2026-04-17 | $1.31 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.72 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$2.65 10-K · filed 2026-03-19 | |||
| 2024-09-30 | -$0.72 10-Q · filed 2025-11-13 | -$1.31 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$2.03 10-Q · filed 2025-11-13 | $0.41 derived: net income ÷ weighted average shares · filed 2026-04-17 | |||
| 2024-06-30 | -$0.59 10-Q · filed 2025-08-07 | -$1.31 10-Q · filed 2025-08-07 | $1.13 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.40 derived: net income ÷ weighted average shares · filed 2026-04-17 | |||
| 2024-03-31 | -$0.72 10-Q · filed 2025-05-12 | $1.72 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.99 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.15 derived: net income ÷ weighted average shares · filed 2026-04-17 | |||
| 2023-12-31 | $2.45 derived: net income ÷ weighted average shares · filed 2026-04-17 | $1.72 derived: net income ÷ weighted average shares · filed 2026-04-17 | $0.87 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$3.28 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$0.73 10-Q · filed 2024-11-07 | -$1.57 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.45 10-Q · filed 2024-11-07 | -$3.71 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2023-06-30 | -$0.84 10-Q · filed 2024-08-07 | -$1.72 10-Q · filed 2024-08-07 | -$2.98 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$4.29 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2023-03-31 | -$0.87 10-Q · filed 2024-05-08 | -$2.13 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.45 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$4.78 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2022-12-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$2.57 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$3.91 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$5.30 10-K · filed 2024-03-19 | |||
| 2022-09-30 | -$1.31 10-Q · filed 2023-11-08 | -$2.65 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$4.04 10-Q · filed 2023-11-08 | ||||
| 2022-06-30 | -$1.33 10-Q · filed 2023-08-08 | -$2.73 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | -$1.40 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$4.21 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$7.16 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$2.44 10-Q · filed 2022-11-10 | -$5.36 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$1.56 10-Q · filed 2022-08-11 | -$2.90 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$1.34 10-Q · filed 2022-05-05 | ||||||
| 2018-12-31 | -$0.28 10-Q · filed 2019-02-13 | -$0.55 10-Q · filed 2019-02-13 | |||||
| 2017-12-31 | -$0.11 10-Q · filed 2019-02-13 | -$0.19 10-Q · filed 2019-02-13 | |||||
| 2017-03-31 | -$0.16 10-Q · filed 2017-05-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.39 10-Q · filed 2017-05-15 | ||||
| 2016-12-31 | -$0.09 10-Q · filed 2018-02-12 | -$0.22 10-Q · filed 2018-02-12 | |||||
| 2016-09-30 | -$0.14 10-Q · filed 2016-11-10 | ||||||
| 2016-03-31 | -$0.15 10-Q · filed 2017-05-15 | -$0.37 derived: net income ÷ weighted average shares · filed 2017-05-15 | $0.03 10-Q · filed 2017-05-15 | ||||
| 2015-12-31 | -$0.22 10-Q · filed 2017-02-10 | $0.20 10-Q · filed 2017-02-10 | |||||
| 2015-09-30 | $0.43 10-Q · filed 2016-11-10 | ||||||
| 2015-03-31 | -$0.23 10-Q · filed 2016-05-09 | -$0.05 10-Q · filed 2015-05-15 | $0.29 derived: net income ÷ weighted average shares · filed 2016-05-09 | -$2.78 10-Q · filed 2016-05-09 | -$0.56 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | $0.55 10-Q · filed 2016-02-05 | $0.11 10-Q · filed 2015-02-13 | -$2.66 10-Q · filed 2016-02-05 | -$0.53 10-Q · filed 2015-02-13 | |||
| 2014-09-30 | -$3.66 10-Q · filed 2015-11-06 | ||||||
| 2014-03-31 | $1.98 10-Q · filed 2015-05-15 | $0.13 8-K · filed 2014-05-27 | -$0.10 10-Q · filed 2015-05-15 | ||||
| 2013-12-31 | -$2.10 10-Q · filed 2015-02-13 | -$2.74 10-Q · filed 2015-02-13 | |||||
| 2013-03-31 | -$0.03 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |